Us Congress 2025-2026 Regular Session

Us Congress House Bill HB4101

Introduced

6/24/25

Refer

6/24/25

Caption

Cancer Drug Parity Act of 2025

Latest US HB4101 Activity

View All Events: US 2025-2026 Regular Session HB4101

Companion Bills

No companion bills found.

Previously Filed As

US HB6301

Cancer Drug Parity Act of 2023

US SB2039

Cancer Drug Parity Act of 2023

US HB8128

Access to Scalp Cooling Therapy Act of 2024

US HB3752

Parity Enforcement Act of 2023

US HB8390

Mental Health and MAMA Act of 2024 Mental Health and Making Access More Affordable Act of 2024

US HB3589

Affordability is Access Act of 2023

US HB9865

Access to Contraception for Servicemembers and Dependents Act of 2024

US SB1698

Affordability is Access Act of 2023

US SB4616

Medicare-X Choice Act of 2024

US HB3561

PATIENT Act of 2023 Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023

Similar Bills

NJ A797

Limits upfront costs for oral anticancer medications for persons covered under certain health benefits plans.

NJ A2464

Limits upfront costs for oral anticancer medications for persons covered under certain health benefits plans.

CA SB421

Health care coverage: cancer treatment.

MI HB4071

Insurance: health insurers; coverage for orally administered anticancer chemotherapy; provide equal treatment for. Amends 1956 PA 218 (MCL 500.100 -500.8302) by adding sec. 3406ff.

US HB6301

Cancer Drug Parity Act of 2023

CA AB1860

Health care coverage: cancer treatment.

US SB2039

Cancer Drug Parity Act of 2023

TX HB438

Relating to health benefit plan coverage for orally administered anticancer medications.